Assignment of interventions to community health centers (CHCs) in districts. by Mehran Asadi-Aliabadi (8383110)

Subjects:

Estimated effects of the intervention packages on the incidence of NCDs metabolic risk factors. by Mehran Asadi-Aliabadi (8383110)

Subjects:

The difference in NCDs metabolic risk factors’ prevalence between the two surveys. by Mehran Asadi-Aliabadi (8383110)

Subjects:

CONSORT flow diagram. by Mehran Asadi-Aliabadi (8383110)

Subjects:

Demographic and economic characteristics of participants (frequencies and percentages). by Mehran Asadi-Aliabadi (8383110)

Subjects:

Districts of intervention and no intervention in IRPONT study. by Mehran Asadi-Aliabadi (8383110)

Subjects:

In individuals affected by PCA, there is a significant downregulation of genes associated with the cholesterol biosynthetic pathway. by Leemon Nikhila (22250736)

ITSA regression results of weekly total cost and cost components per capita for inpatients in the non-surgical group before and after DIP payment intervention. by Chenxuan Zhu (22622476)

Table 1_Prognostic significance of early alpha fetoprotein and des-gamma carboxy prothrombin responses in unresectable hepatocellular carcinoma patients undergoing triple combinati... by Teng Zhang (457128)

“…Background<p>Recent advancements in combination therapy for unresectable hepatocellular carcinoma (uHCC) have shown promise, but reliable serological prognostic indicators are currently lacking for patients undergoing triple combination therapy of stereotactic body radiation therapy (SBRT), immunotherapy, and targeted therapy. We aimed to investigate the prognostic significance of early alpha fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) responses in these patients.…”

Baseline characteristics of propensity score-matched migrated and non-migrated primary knee arthroplasty patients. by Fanqiang Meng (4786071)

Changes in connectivity of the mPFC among responders and non-responders. by Karel Joineau (21799908)

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. by Mingee Choi (15250732)

Subjects:

Ischemic heart disease-related mortality trends in older adult population and stratified for metropolitan vs. non-metropolitan in 1999–2020. by Fakhar Latif (19760906)

Spearman correlation analysis of the RAAS and glucose metabolism indicators before and after treatment in DKD and non-DKD patients. by Ningning Wang (560944)

<i>Aedes aegypti</i> database from SAGO traps. by Jesús A. Aguilar-Durán (9931967)

“…IVM treatment reduced the number of females per trap per week from 3.29 ± 0.24 to 2.41 ± 0.20 (33.7% reduction), AGO from 1.58 ± 0.17 to 0.25 ± 0.05 (85.2% reduction), and AGO + IVM from 1.49 ± 0.17 to 0.53 ± 0.08 (67.78% reduction), based on Henderson’s formula. We observed a non-significant increase in the control area (no treatment provided) in the mosquito populations, increasing from 2.94 ± 0.24 in the pretreatment period to 3.25 ± 0.28 of the post treatment period.…”

Graph of the risk of bias for the included randomized controlled trials (A); Summary of the risk of bias for the included randomized controlled trials (B). by Zhuoyang Xia (21354186)

Subjects:

SBP3 KD decreases the surface localization of VESA-1. by Atefeh Fathi (7370876)

Comparison of postoperative outcomes and financial burden between migrated and non-migrated primary knee arthroplasty patients. by Fanqiang Meng (4786071)

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

“…Data represent mean values ± standard deviation, n = 3. <b>Legends:</b> ns: non-significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.…”

Odds ratio of multivariable analysis of factors for non-typhoidal <i>Salmonella.</i> by Amete Mihret Teshale (12072758)